Dong-A ST Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
Phase I Clinical Trial of DA-6886 in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 105
- Registration Number
- NCT01633723
- Locations
- π°π·
ASAN medical center, Seoul, Songpa-gu, Korea, Republic of
Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 63
- Registration Number
- NCT01553721
- Locations
- π°π·
Pusan national University Hospital, Pusan, Korea, Republic of
π°π·Chonnam National University Hospital, Gwang-ju, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Chongno-gu, 28 Yongon-dong, Korea, Republic of
Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 65
- Registration Number
- NCT01526122
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
- First Posted Date
- 2010-07-15
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Registration Number
- NCT01162954
- Locations
- π°π·
Clinical Research Institue, Seoul National University Hospital, Seoul, Chongno-Gu, Yon-Gon Dong 28, Korea, Republic of
The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00967772
- Locations
- π°π·
Clinical Trial center, Clinical Research institute, Seoul National University Hospital, Seoul, Korea, Republic of
Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Registration Number
- NCT00959777
- Locations
- π°π·
Clinical Trials center, Clinical Research institute, Seoul National University Hospital, Seoul, Yonggon-Dong, Chongono-Gu, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath